{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:13:11Z","timestamp":1760890391771,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0310102","JP15K08507"],"award-info":[{"award-number":["JP20fk0310102","JP15K08507"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20fk0310102","JP15K08507"],"award-info":[{"award-number":["JP20fk0310102","JP15K08507"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.virusres.2021.198565","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T20:22:24Z","timestamp":1632169344000},"page":"198565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly"],"prefix":"10.1016","volume":"306","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6698-5701","authenticated-orcid":false,"given":"Manabu","family":"Yamasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norie","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-3100","authenticated-orcid":false,"given":"Kazuaki","family":"Matoba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Kanegae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2021.198565_bib0001","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3748\/wjg.v13.i1.48","article-title":"Hepatitis B virus replication","volume":"13","author":"Beck","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.virusres.2021.198565_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00560-17","article-title":"Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus","volume":"61","author":"Berke","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2021.198565_bib0003","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1128\/JVI.00582-13","article-title":"Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids","volume":"87","author":"Campagna","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198565_bib0004","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jmv.22014","article-title":"Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents","volume":"83","author":"Cheng","year":"2011","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virusres.2021.198565_bib0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2893.2010.01321.x","article-title":"Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy","volume":"18","author":"Coffin","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2021.198565_bib0006","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s40265-017-0769-2","article-title":"Drugs in development for hepatitis B","volume":"77","author":"Dawood","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.virusres.2021.198565_bib0007","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.antiviral.2017.11.015","article-title":"The diverse functions of the hepatitis B core\/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals","volume":"149","author":"Diab","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2021.198565_bib0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cld.2010.05.001","article-title":"Hepatitis B virology for clinicians","volume":"14","author":"Doo","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.virusres.2021.198565_bib0009","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.jhep.2016.02.016","article-title":"New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus","volume":"64","author":"Durantel","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virusres.2021.198565_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2021.198565_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006658","article-title":"HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways","volume":"13","author":"Guo","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2021.198565_bib0012","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acs.jcim.6b00763","article-title":"Structure-based rational design of novel inhibitors against fructose-1,6-bisphosphate aldolase from Candida albicans","volume":"57","author":"Han","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.virusres.2021.198565_bib0013","unstructured":"Hepatitis B Foundation, 2020. Drug Watch. In: Treatment & Management [website]. Updated Dec 2020. https:\/\/www.hepb.org\/treatment-and-management\/drug-watch\/."},{"key":"10.1016\/j.virusres.2021.198565_bib0014","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2021.198565_bib0015","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2021.198565_bib0016","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1128\/AAC.41.8.1715","article-title":"Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication","volume":"41","author":"Ladner","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2021.198565_bib0017","article-title":"Preclinical characterization of NVR 3-778, a first-in-class capsid assembly modulator against hepatitis B virus","volume":"63","author":"Lam","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2021.198565_bib0018","doi-asserted-by":"crossref","first-page":"11916","DOI":"10.1128\/JVI.05373-11","article-title":"Roles of the envelope proteins in the amplification of covalently closed circular DNA and completion of synthesis of the plus-strand DNA in hepatitis B virus","volume":"85","author":"Lentz","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198565_bib0019","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/v11050427","article-title":"Human hepatitis B virus core P protein inhibits IFN\u03b1-induced IFITM1 expression by interacting with BAF200","volume":"11","author":"Li","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2021.198565_bib0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/14728222.2017.1397134","article-title":"Hepatitis B core protein as a therapeutic target","volume":"21","author":"Mak","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.virusres.2021.198565_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00082-18","article-title":"Preclinical profile of AB-423, an inhibitor of hepatitis B virus pregenomic RNA encapsidation","volume":"62","author":"Mani","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virusres.2021.198565_bib0022","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1021\/acs.jmedchem.6b01442","article-title":"Past, current, and future developments of therapeutic agents for treatment of chronic hepatitis B virus infection","volume":"60","author":"Pei","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virusres.2021.198565_bib0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.immuni.2014.12.016","article-title":"The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus","volume":"42","author":"Sato","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2021.198565_bib0024","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection","volume":"479-480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2021.198565_bib0025","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2021.198565_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cld.577","article-title":"New pharmacological approaches to a functional cure of hepatitis B","volume":"8","author":"Seto","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.virusres.2021.198565_bib0027","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Stray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2021.198565_bib0028","doi-asserted-by":"crossref","first-page":"41851","DOI":"10.1038\/srep41851","article-title":"Efficient genome replication of hepatitis B virus using adenovirus vector: a compact pregenomic RNA-expression unit","volume":"7","author":"Suzuki","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.virusres.2021.198565_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ja.2017.115","article-title":"Current landscape and future prospects of antiviral drugs derived from microbial products","volume":"71","author":"Takizawa","year":"2017","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.virusres.2021.198565_bib0030","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1128\/JVI.72.7.5789-5796.1998","article-title":"The duck hepatitis B virus polymerase is activated by its RNA packaging signal, epsilon","volume":"72","author":"Tavis","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2021.198565_bib0031","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/jvh.12341","article-title":"Combination therapy of interferon and nucleotide\/nucleoside analogues for chronic hepatitis B","volume":"21","author":"Wong","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.virusres.2021.198565_bib0032","unstructured":"World Health Organization, 2016. Global health sector strategy on viral hepatitis 2016-2021. Towards ending viral hepatitis. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/246177."},{"key":"10.1016\/j.virusres.2021.198565_bib0033","unstructured":"World Health Organization, 2020. Hepatitis B. WHO Fact sheet. In: Newsroom [website]. Reviewed July 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"10.1016\/j.virusres.2021.198565_bib0034","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJMoa013215","article-title":"Hepatitis B e antigen and the risk of hepatocellular carcinoma","volume":"347","author":"Yang","year":"2002","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.virusres.2021.198565_bib0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.8b00337","article-title":"Treatment of chronic hepatitis B virus infection using small molecule modulators of nucleocapsid assembly: Recent advances and perspectives","volume":"5","author":"Yang","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virusres.2021.198565_bib0036","doi-asserted-by":"crossref","first-page":"42374","DOI":"10.1038\/srep42374","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virusres.2021.198565_bib0037","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nprot.2007.60","article-title":"In vitro screening for molecules that affect virus capsid assembly (and other protein association reactions)","volume":"2","author":"Zlotnick","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virusres.2021.198565_bib0038","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: A pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antiviral Res."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170221002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:14:27Z","timestamp":1759155267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170221002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":38,"alternative-id":["S0168170221002720"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198565","relation":{},"ISSN":["0168-1702"],"issn-type":[{"type":"print","value":"0168-1702"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2021.198565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198565"}}